Anti-Amyloid-Beta Antibodies can Improve Memory Performance in Alzheimer's Disease Patients

Amyloid-beta assemblies may be one of the most important causes of Alzheimer's disease earlier.

Passive immunization of anti-amyloid-beta antibodies can reduce amyloid-beta burden and improved memory performance in various Alzheimer's disease animal models or patients.

Screening humanized antibodies from a human Fab phage display library is an effective and quick method to obtain beta-amyloid oligomers. Thus, a recent study published in the Neural Regeneration Research (Vol. 8, No. 33, 2013) successfully constructed a na�ve human Fab library and obtained a human Fab antibody and a single-domain antibody that specifically recognized amyloid-beta (Aβ)42 oligomers.

Source: Eurekalert